These discordant patients showed the same clinical features of 211 NXP2-negative patients; in particular, no differences were found regarding features associated with NXP2 clinical phenotype (i.e. DM rash, calcinosis, dysphagia) (Table 1 supplemental material). This evidence concerns the gene MORC3 and dermatomyositis.